Another Republican Steps Up To Defend Bob Corker And

New Post Public Reply Private Reply Replies (0) Message Board

Oct 10, 2017 at 12:35 AM 951

Quote:

Another Republican Steps Up To Defend Bob Corker And Encourage More GOPers To Take On Trump

By Sean Colarossi on Mon, Oct 9th, 2017 at 10:00 pm

"I think more of my colleagues should speak up. They say things privately that they don't say publicly.

Whoa, back up a moment Charlie. Haven't you just defined the core of conservative thought and action/inaction? Talk the talk, but don't walk the walk? Do as we say, not as we do?

The chorus of Republicans speaking out against Donald Trump continued to gain traction on Monday, with GOP Congressman Charlie Dent leaping to the defense of Tennessee Bob Corker and urging more members of his party to take on the president.

In an interview on MSNBC, Dent said, “I’m glad that Senator Corker” has spoken out against Trump.

Video: http://www.politicususa.com/2017/10/09/republ...trump.html

Dent, who has announced that he will not be seeking re-election at the end of his term, was asked whether it’s easier to criticize Trump because he won’t be returning to Congress, and he responded:

Well, I was critical before the 2016 election, I never endorsed Trump. So I’ll be very honest with you. … A lot of these comments from the president have been disquieting, to say the least.

Yep, that's the least you could say. Too bad that the 'pair' you just grew isn't 'organic' rather than Janis Joplin's definition of freedom belatedly, conveniently, coming to your 'consciousness'.

Not running for office again is a real spine stiffener, eh?
You and Corker should start an orthopedic practice; "Spine Stiffeners, LTD".

Jesus, if they were casting a remake of "The Wizard of Oz" there wouldn't be near enough 'cowardly lion' costumes to meet the demand from GOPERS!

And let’s be honest, we’ve had a lot of these emperor has no clothes moments, and I’m glad that Sen. Corker has brought voice to this. We are concerned – my colleagues, my Republican colleagues in the House and Senate are concerned by much of the dysfunction and disorder and chaos at the White House. … We have these conversations all the time and we have to do better and I think more of my colleagues should speak up. They say things privately that they don’t say publicly.

As Dent said, it’s not just retiring Republicans that should be speaking out against this dangerous president. All Republicans with a conscience should be standing up, especially those who are running for re-election. That’s when it will matter most.

If they don’t speak out and say that enough is enough, then it will only enable the president to continue behaving so dangerously. That may have been okay during the campaign when he didn’t have his hands on the nuclear codes, but now he has real power, and his irresponsible use of that power could endanger the United States and the world.

With powerful GOP Sen. Bob Corker leading the charge against Trump and many more members of the party privately echoing Corker’s concerns, it’s only a matter of time before those behind-closed-doors frustrations are heard publicly.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Surfing Dogs Ride Waves, Support Orphan Pets

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Top 5 Most Recently Viewed Articles

Microbot Medical Secures $13 Million in Recent Offering

Microbot Medical Makes Strategic Move with $13 Million Offering Microbot Medical Inc. (NASDAQ: MBOT) has recently taken an important step to elevate its operations by entering into definitive agreements to sell 6,103,289 shares of its common stock at a price of $2.13 per share. This registered direct offering, priced at-the-market under Nasdaq rules, underscores the...

Evolv Technologies Faces Class Action Lawsuit: Know Your Rights

Understanding the Evolv Technologies Holdings Class Action Recent developments have raised significant concerns among shareholders of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV). A class action lawsuit is currently in progress, prompting investors to scrutinize the implications of false statements made by the company. The allegations revolve around misleading...

Rhino Rescue Unveils Innovative First Aid Kits for Adventurers

Rhino Rescue Launches Innovative Products for Outdoor Safety Rhino Rescue has made a remarkable stride in enhancing outdoor safety with its new lineup of first aid kits targeted towards adventurers and everyday users alike. The release of the Rhino Rescue Mini First Aid Kit, along with home and camping-specific options, marks an exciting development in the company’s...

RUSH's 2026 Tour: Celebrating Legacy and New Beginnings

RUSH's 2026 Tour: A Celebration of Music and Legacy Geddy Lee and Alex Lifeson are set to celebrate over 50 years of RUSH's musical journey as they announce a special headline tour for 2026, named the Fifty Something Tour. This tour not only commemorates the incredible music and legacy of RUSH, but also pays tribute to their late drummer and lyricist Neil Peart, whose...

BioSyent Inc. Announces Quarterly Dividend for Shareholders MISSISSAUGA, Ontario — BioSyent Inc. (TSX Venture: RX) is thrilled to communicate that its Board of Directors has approved a quarterly dividend of $0.05 per common share. This dividend will be paid in Canadian Dollars on a specified date to shareholders who are on record, enhancing the company's ongoing...